Thus, our results strongly suggest that the binding of SIRT3 with NMNAT2 is a novel regulator of cell proliferation and apoptosis in NSCLC cell lines implicating the interaction between SIRT3 and NMNAT2 and energy metabolism associated with it. The gene discussed is SIRT3; the disease is non-small cell lung carcinoma.